PineBridge Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,056
| Closed | -$1M | – | 683 |
|
|
2025
Q1 | $1M | Sell |
9,056
-21,059
| -70% | -$2.33M | 0.01% | 500 |
|
|
2024
Q4 | $4.11M | Sell |
30,115
-227
| -0.7% | -$31K | 0.03% | 348 |
|
|
2024
Q3 | $3.5M | Buy |
+30,342
| New | +$3.5M | 0.03% | 363 |
|
|
2023
Q4 | – | Sell |
-12,399
| Closed | -$1.39M | – | 629 |
|
|
2023
Q3 | $1.39M | Sell |
12,399
-13,674
| -52% | -$1.54M | 0.02% | 406 |
|
|
2023
Q2 | $2.46M | Buy |
26,073
+18,288
| +235% | +$1.72M | 0.03% | 344 |
|
|
2023
Q1 | $788K | Buy |
+7,785
| New | +$788K | 0.01% | 419 |
|